Cargando…

A Regimen of Taxol, Ifosfamide, and Platinum for Recurrent Advanced Squamous Cell Cancer of the Anal Canal

The typically recommended chemotherapy options in metastatic anal cancer generally yield partial remissions with limited benefit for the majority of patients. TIP is a regimen containing paclitaxel (Taxol), ifosfamide, and cisplatin that is known to have significant activity in patients with squamou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golub, Diana V., Civelek, A. Cahid, Sharma, Vivek R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265251/ https://www.ncbi.nlm.nih.gov/pubmed/22295202 http://dx.doi.org/10.1155/2011/163736

Ejemplares similares

Platinum-Taxol non-cross resistance in epithelial ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1995)

The impact of anaemia on treatment outcome in patients with squamous cell carcinoma of anal canal and anal margin
por: Oblak, Irena, et al.
Publicado: (2016)

Editorial: Global excellence in nuclear medicine: North America
por: Jha, Abhishek, et al.
Publicado: (2023)

Melanoma of the anal canal
por: Parra, Rogerio Serafim, et al.
Publicado: (2010)

Paclitaxel–ifosfamide–carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours
por: Kosmas, C, et al.
Publicado: (2011)

Narrow-band imaging for diagnosis of squamous cell carcinoma in the anal canal
por: Takeuchi, Yoji, et al.
Publicado: (2017)

Nonplatinum‐based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population‐based Danish anal cancer group study
por: Truelsen, Christina Glismand, et al.
Publicado: (2021)

Beware of anal fissures: pemphigus vulgaris of the anal canal
por: Karatzi, Chara, et al.
Publicado: (2019)

Synergistic cytotoxicity of cisplatin and Taxol in overcoming Taxol resistance through the inhibition of LDHA in oral squamous cell carcinoma
por: FENG, LIN, et al.
Publicado: (2015)

Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report
por: Sokolova, Alexandra, et al.
Publicado: (2017)

Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience
por: Kim, Kyung Hwan, et al.
Publicado: (2013)

Early Squamous Cell Carcinoma of the Anal Canal Resected by Endoscopic Submucosal Dissection
por: Tamaru, Yuzuru, et al.
Publicado: (2015)

Endoscopic submucosal dissection to treat squamous cell carcinoma in situ of the anal canal
por: Lajin, Michael, et al.
Publicado: (2022)

Transitioning ifosfamide chemotherapy regimens to the ambulatory setting: reviewing cost savings and safety profile
por: Banh, Cindy, et al.
Publicado: (2021)

The application of (18)F-FDG PET/CT imaging for human hepatocellular carcinoma: a narrative review
por: Yao, Yong, et al.
Publicado: (2023)

Intra-arterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal: an active treatment modality with curative potential
por: Roth, A D, et al.
Publicado: (2000)

Black Anal Canal: Acute Necrosis
por: Barbeiro, Sandra, et al.
Publicado: (2016)

A Case of Lymphangioma of the Anal Canal
por: Karapashis, Kyriacos, et al.
Publicado: (2018)

SMILE-like lesion in the anal canal
por: Sekar, Aravind, et al.
Publicado: (2021)

Characteristics of anal canal cancer in Japan
por: Yamada, Kazutaka, et al.
Publicado: (2022)

Anal Canal Duplication Mimicking Recurrent Abscess: A Case Report and Review of the Literature
por: Li, Dandan, et al.
Publicado: (2022)

Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC)
por: Baldini, E, et al.
Publicado: (2001)

Ogilvie Syndrome in a Refractory Germ Cell Tumor Treated with Vinblastine, Ifosfamide and Cisplatin Regimen
por: Varayathu, Hrishi, et al.
Publicado: (2020)

Mitomycin and 5‐fluorouracil for second‐line treatment of metastatic squamous cell carcinomas of the anal canal
por: Saint, Angélique, et al.
Publicado: (2019)

The growing pains of ifosfamide
por: Sprangers, Ben, et al.
Publicado: (2020)

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)
por: Rao, S., et al.
Publicado: (2022)

Cloacal type defect of the anal canal following an obstetric anal sphincter trauma
por: Stavros, Sofoklis, et al.
Publicado: (2021)

Metachronous tubulovillous and tubular adenomas of the anal canal
por: Nozawa, Hiroaki, et al.
Publicado: (2015)

A Bleeding Dieulafoy's Lesion in the Anal Canal
por: Gurala, Dhineshreddy, et al.
Publicado: (2019)

Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans
por: Menkarios, Cathy, et al.
Publicado: (2007)

Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma
por: Michelagnoli, M P, et al.
Publicado: (1999)

Stage IV anal canal squamous cell carcinoma with long-term survival: a case report
por: Sawai, Katsuji, et al.
Publicado: (2022)

Hepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative Approach
por: Rogers, Jane E., et al.
Publicado: (2023)

Is elective inguinal radiotherapy necessary for locally advanced rectal adenocarcinoma invading anal canal?
por: Yeo, Seung-Gu, et al.
Publicado: (2014)

Doxorubicin and ifosfamide for recurrent renal synovial sarcoma: The first case report in Indonesia
por: Fitra, Ahmad Fathira, et al.
Publicado: (2022)

Ifosfamide nephrotoxicity in adult patients
por: Ensergueix, Gaël, et al.
Publicado: (2019)

A retrospective evaluation of activity of gemcitabine/platinum regimens in the treatment of recurrent ovarian cancer
por: Le, Tran N., et al.
Publicado: (2017)

Molecular Image-Guided Theranostic and Personalized Medicine 2013
por: Zhang, Hong, et al.
Publicado: (2014)

Molecular Image-Guided Theranostic and Personalized Medicine 2014
por: Zhang, Hong, et al.
Publicado: (2015)

Phase I study of docetaxel plus ifosfamide in patients with advanced cancer
por: Marx, G, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_928g15ivllspqkjqs6448urh5k